BACKGROUND: The annual mortality rate of human rabies in rural Africa is 3.6 deaths per 100 000 persons. Rabies can be prevented with prompt postexposure prophylaxis, but this is costly and often inaccessible in rural Africa. Because 99% of human exposures occur through rabid dogs, canine vaccination also prevents transmission of rabies to humans. OBJECTIVE: To evaluate the cost-effectiveness of rabies control through annual canine vaccination campaigns in rural sub-Saharan Africa. DESIGN: We model transmission dynamics in dogs and wildlife and assess empirical uncertainty in the biological variables to make probability-based evaluations of cost-effectiveness. DATA SOURCES: Epidemiologic variables from a contact-tracing study and literature and cost data from ongoing vaccination campaigns. TARGET POPULATION: Two districts of rural Tanzania: Ngorongoro and Serengeti. TIME HORIZON: 10 years. PERSPECTIVE: Health policymaker. INTERVENTION: Vaccination coverage ranging from 0% to 95% in increments of 5%. OUTCOME MEASURES: Life-years for health outcomes and 2010 U.S. dollars for economic outcomes. RESULTS OF BASE-CASE ANALYSIS: Annual canine vaccination campaigns were very cost-effective in both districts compared with no canine vaccination. In Serengeti, annual campaigns with as much as 70% coverage were cost-saving. RESULTS OF SENSITIVITY ANALYSIS: Across a wide range of variable assumptions and levels of societal willingness to pay for life-years, the optimal vaccination coverage for Serengeti was 70%. In Ngorongoro, although optimal coverage depended on willingness to pay, vaccination campaigns were always cost-effective and lifesaving and therefore preferred. LIMITATION: Canine vaccination was very cost-effective in both districts, but there was greater uncertainty about the optimal coverage in Ngorongoro. CONCLUSION: Annual canine rabies vaccination campaigns conferred extraordinary value and dramatically reduced the health burden of rabies. PRIMARY FUNDING SOURCE: National Institutes of Health.
BACKGROUND: The annual mortality rate of human rabies in rural Africa is 3.6 deaths per 100 000 persons. Rabies can be prevented with prompt postexposure prophylaxis, but this is costly and often inaccessible in rural Africa. Because 99% of human exposures occur through rabid dogs, canine vaccination also prevents transmission of rabies to humans. OBJECTIVE: To evaluate the cost-effectiveness of rabies control through annual canine vaccination campaigns in rural sub-Saharan Africa. DESIGN: We model transmission dynamics in dogs and wildlife and assess empirical uncertainty in the biological variables to make probability-based evaluations of cost-effectiveness. DATA SOURCES: Epidemiologic variables from a contact-tracing study and literature and cost data from ongoing vaccination campaigns. TARGET POPULATION: Two districts of rural Tanzania: Ngorongoro and Serengeti. TIME HORIZON: 10 years. PERSPECTIVE: Health policymaker. INTERVENTION: Vaccination coverage ranging from 0% to 95% in increments of 5%. OUTCOME MEASURES: Life-years for health outcomes and 2010 U.S. dollars for economic outcomes. RESULTS OF BASE-CASE ANALYSIS: Annual canine vaccination campaigns were very cost-effective in both districts compared with no canine vaccination. In Serengeti, annual campaigns with as much as 70% coverage were cost-saving. RESULTS OF SENSITIVITY ANALYSIS: Across a wide range of variable assumptions and levels of societal willingness to pay for life-years, the optimal vaccination coverage for Serengeti was 70%. In Ngorongoro, although optimal coverage depended on willingness to pay, vaccination campaigns were always cost-effective and lifesaving and therefore preferred. LIMITATION: Canine vaccination was very cost-effective in both districts, but there was greater uncertainty about the optimal coverage in Ngorongoro. CONCLUSION: Annual canine rabies vaccination campaigns conferred extraordinary value and dramatically reduced the health burden of rabies. PRIMARY FUNDING SOURCE: National Institutes of Health.
Authors: J M Minke; J Bouvet; F Cliquet; M Wasniewski; A L Guiot; L Lemaitre; C Cariou; V Cozette; L Vergne; P M Guigal Journal: Vet Microbiol Date: 2008-07-05 Impact factor: 3.293
Authors: Tiziana Lembo; Katie Hampson; Daniel T Haydon; Meggan Craft; Andy Dobson; Jonathan Dushoff; Eblate Ernest; Richard Hoare; Magai Kaare; Titus Mlengeya; Christine Mentzel; Sarah Cleaveland Journal: J Appl Ecol Date: 2008-08 Impact factor: 6.528
Authors: U Kayali; R Mindekem; N Yémadji; P Vounatsou; Y Kaninga; A G Ndoutamia; J Zinsstag Journal: Bull World Health Organ Date: 2003-11-25 Impact factor: 9.408
Authors: Alyssa M Bilinski; Meagan C Fitzpatrick; Charles E Rupprecht; A David Paltiel; Alison P Galvani Journal: Proc Biol Sci Date: 2016-11-16 Impact factor: 5.349
Authors: Melissa Dominique Etheart; Maxwell Kligerman; Pierre Dilius Augustin; Jesse D Blanton; Benjamin Monroe; Ludder Fleurinord; Max Millien; Kelly Crowdis; Natael Fenelon; Ryan MacLaren Wallace Journal: Lancet Glob Health Date: 2017-10 Impact factor: 26.763
Authors: Meagan C Fitzpatrick; Hiral A Shah; Abhishek Pandey; Alyssa M Bilinski; Manish Kakkar; Andrew D Clark; Jeffrey P Townsend; Syed Shahid Abbas; Alison P Galvani Journal: Proc Natl Acad Sci U S A Date: 2016-12-20 Impact factor: 11.205
Authors: Jessie L Dyer; Pamela Yager; Lillian Orciari; Lauren Greenberg; Ryan Wallace; Cathleen A Hanlon; Jesse D Blanton Journal: J Am Vet Med Assoc Date: 2014-11-15 Impact factor: 1.936
Authors: Felix Lankester; Katie Hampson; Tiziana Lembo; Guy Palmer; Louise Taylor; Sarah Cleaveland Journal: Science Date: 2014-09-26 Impact factor: 47.728
Authors: Katie Hampson; Laurent Coudeville; Tiziana Lembo; Maganga Sambo; Alexia Kieffer; Michaël Attlan; Jacques Barrat; Jesse D Blanton; Deborah J Briggs; Sarah Cleaveland; Peter Costa; Conrad M Freuling; Elly Hiby; Lea Knopf; Fernando Leanes; François-Xavier Meslin; Artem Metlin; Mary Elizabeth Miranda; Thomas Müller; Louis H Nel; Sergio Recuenco; Charles E Rupprecht; Carolin Schumacher; Louise Taylor; Marco Antonio Natal Vigilato; Jakob Zinsstag; Jonathan Dushoff Journal: PLoS Negl Trop Dis Date: 2015-04-16